Cardiovascular (CV) disease is the leading cause of morbidity and mortality in the US and worldwide. Non-invasive imaging provides valuable information to assess differential diagnosis and to help formulate a management plan. Unfortunately, most existing training programs in CV imaging offer only fragmented and discipline-constrained training opportunities, and very few offer training that incorporates clinicl and translational research in imaging science. This is the first competing renewal application for Brigham and Women's Hospital noninvasive cardiovascular imaging T32 program. This program offers post-doctoral research training for individuals with an MD, or combined MD/PhD degrees, who have completed clinical training in cardiology, radiology, or cardiovascular imaging who are committed to pursuing an academic career in CV imaging science. Our objective is to provide a multidisciplinary research environment that integrates CV biology, pharmacology, and imaging technology, with which to train clinician-scientists in translational imaging science. All the fellws have presented their work at national meetings. In the first 3.5 years of this T32 grant, our trainees have authored 63 manuscripts (some currently under review) with more than 90% being original contributions. Importantly, those who completed training to date have obtained academic faculty positions and have already obtained or are actively pursuing independent funding opportunities, all strong indicators of program success. Our mentors are primarily comprised of cardiologists and radiologists, but also include faculty from Pulmonary Medicine, Pathology, Anesthesia, Endocrinology, and the Center for Systems Biology at MGH. All of the mentors have an extensive portfolio of collaborations. We offer research opportunities in seven primary areas of imaging research: (1) molecular imaging, (2) myocardial structure and function, (3) cell-based therapy, (4) genetics, (5) pulmonary hypertension, (6) vascular imaging, and (7) outcomes research. The proposed program supports 3 positions/year for two years of continued research training. With this renewal, we continue our primary goals of providing leadership in academic cardiovascular imaging and training future leaders in imaging science to improve outcomes in cardiovascular disease.

Public Health Relevance

The proposed competing application of our T32 training program is designed to train clinician-scientists in cardiovascular imaging to prepare them for successful and productive academic careers. The program offers mutli-disciplinary training in a broad and diverse spectrum of areas in cardiovascular medicine with relevance to imaging science. With this renewal, we continue our primary goals of providing leadership in academic cardiovascular imaging and training future leaders in imaging science to improve outcomes in cardiovascular disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL094301-09
Application #
9515653
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Huang, Li-Shin
Project Start
2010-07-01
Project End
2020-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
9
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
Gupta, Ankur; Harrington, Meagan; Albert, Christine M et al. (2018) Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction. JACC Clin Electrophysiol 4:1200-1210
Gupta, Ankur; Yancy, Clyde W; Fonarow, Gregg C (2018) Evaluating Readmission-Need for More Clarity on Methods-Reply. JAMA Cardiol 3:265-266
Gupta, Ankur; Bajaj, Navkaranbir S; Arora, Pankaj et al. (2018) FFR-guided multivessel stenting reduces urgent revascularization compared with infarct-related artery only stenting in ST-elevation myocardial infarction: A meta-analysis of randomized controlled trials. Int J Cardiol 252:63-67
Venkatraman, A; Hardas, S; Patel, N et al. (2018) Galectin-3: an emerging biomarker in stroke and cerebrovascular diseases. Eur J Neurol 25:238-246
Shinde, Arti V; Su, Ya; Palanski, Brad A et al. (2018) Pharmacologic inhibition of the enzymatic effects of tissue transglutaminase reduces cardiac fibrosis and attenuates cardiomyocyte hypertrophy following pressure overload. J Mol Cell Cardiol 117:36-48
Vaduganathan, Muthiah; Qamar, Arman; Gupta, Ankur et al. (2018) Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials. Am J Med 131:575-577
Wu, Candace; Singh, Avinainder; Collins, Bradley et al. (2018) Causes of Troponin Elevation and Associated Mortality in Young Patients. Am J Med 131:284-292.e1
Kalra, Rajat; Arora, Garima; Patel, Nirav et al. (2018) Targeted Temperature Management After Cardiac Arrest: Systematic Review and Meta-analyses. Anesth Analg 126:867-875
Fujikura, Kana; Peltzer, Bradley; Tiwari, Nidhish et al. (2018) Reduced global longitudinal strain is associated with increased risk of cardiovascular events or death after kidney transplant. Int J Cardiol 272:323-328
Singh, Avinainder; Collins, Bradley L; Gupta, Ankur et al. (2018) Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry. J Am Coll Cardiol 71:292-302

Showing the most recent 10 out of 132 publications